 |
 |
|
Newsroom - Clients - ERXX
The following news and investment research items reflect some of the recent business activity for selected clients of Empire Relations Group, Inc. Additional information for investment research can be found in the featured clients section. News and investment research are for informational purposes only.
Eco-Rx, Inc. Inc
Eco-Rx Announces That Its RX 400 Air Purifier Kills Airborne Tuberculosis
NORTH MIAMI BEACH, FL--(MARKET WIRE)--Jun 5, 2007 -- Eco-Rx (Other OTC:ERXX.PK - News), producer of proprietary air purification products, said today that its model RX-400 air purifier has the capability of killing airborne Tuberculosis (TB). TB is a bacterial agent which is annually responsible for the deaths of over a million and a half people worldwide.
The RX 400, which received a Class II medical device listing from the U.S. Food and Drug Administration, purifies the air by drawing contaminants into its sealed chamber and exposing the bacteria to high powered UV-C. The recent highly publicized case of a TB carrier who exposed airline passengers and others while traveling is an example of how serious a threat TB and other bacteria can be when an enclosed space is left untreated.
Paul Taccini, President of Eco-Rx, commented, "The Company will be contacting airlines and other modes of public transportation to make them aware of the RX 400's ability to kill over 99% of airborne bacterial agents on a 'first pass' basis. We also intend to recommend the use of the RX 400 in their waiting rooms and clubs."
Mr. Taccini continued, "We see a tremendous need for our products, which utilize this patented technology. This translates into a huge market opportunity for the Company. If one considers the bacterial danger posed to humans in hospitals, offices, hotels, restaurants, theaters, schools and stores where you can have large numbers of people in an enclosed area, it's not inconceivable that the demand for Eco-Rx's products will be positively impacted. Eco-Rx is positioned to pursue an aggressive campaign with institutions, hotels, commercial venues and public transportation to help them resolve these airborne threats."
There are several benefits that accrue to Eco-Rx for having certification as an FDA Class II medical device. Certification lends credibility to the technology in the health care field. It also increases credibility in the consumer markets, separating our product from non-certified air purifiers, thus enhancing overall marketing and sales opportunities.
About Eco-Rx
Eco-Rx, Inc. produces proprietary products utilizing high-intensity ultraviolet radiation (UVC) inside a "killing chamber" (a replaceable cartridge). The UV destroys airborne bacteria. Extensive independent testing by an EPA and FDA certified laboratory confirms that the unique technology kills airborne bacteria including: Bacillus subtilis, Pseudomonas aeruginosa, Staphylococcus aureus, and Klebsiella pneumonia. The machine does not produce nor use ozone. Eco-Rx combines its purification technology, a sophisticated electronic ballast system, with an electronic control module in a product that is totally effective and user-friendly. The technology uses a replaceable cartridge providing 12 months of continuous operation (24/7).
Disclaimer
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release include expectations which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Factors that might cause or contribute to such differences include, but are not limited to: difficulties encountered in launching a new product, competition and receiving timely shipments from the manufacturer in China. Eco-Rx undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement.
Joseph Peiken
305.937.1862
|
|
|
|
|
Top of Page |
E-mail This Page |
Back to Newsroom
|
|
|
 |
| |
 |
|
|
About Eco-Rx, Inc.
Eco-Rx, Inc. is engaged in the research and development, manufacturing and marketing of
high quality ultraviolet (UV-C) air purifiers for the medical industry, business and households
throughout North America.
To link to this corporate profile in our members area click here (You must be a registered member to see profile).
|
|
|
 |
What Our Visitors Say . . .
"I am very impressed with your Advisory Panel" - Dave Oppenheim - Senior Vice President, Westrock Advisors
|
